The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

Title: The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease

Volume: 16 Issue: 26

Author(s): H. M. Viola, W. A. Macdonald, H. Tang and L. C. Hool

Affiliation:

Keywords: L-type Ca2+ channel, calcium homeostasis, reactive oxygen species, cardiac hypertrophy, L-type Ca2+ channel antagonists

Abstract: The L-type Ca2+ channel plays a critical role in cardiac function as the main route for entry of calcium into cardiac myocytes. It is essential to excitability as it shapes the long plateau phase of the cardiac action potential that is unique to cardiac ventricular myocytes. It is necessary for contraction as it triggers the release of calcium from sarcoplasmic reticulum stores for actin-myosin interaction. The L-type Ca2+ channel also regulates cytoplasmic calcium levels. It is well recognized that an increase in intracellular calcium is involved in the activation of growth-promoting signal pathways. Recently, reactive oxygen species have been implicated in the activation of signal pathways and the development of pathological hypertrophy. There is now evidence that implicates activation of the L-type Ca2+ channel with persistent alterations in calcium homeostasis and cellular reactive oxygen species production as a possible trigger of cardiac hypertrophy. A number of different approaches have been used to modify channel function with the view to preventing ischemiareperfusion injury, cardiac hypertrophy or cardiac failure providing good evidence that the L-type Ca2+ channel may be an efficacious target in the prevention of cardiac pathology.

Cite this article as:

Viola M. H., Macdonald A. W., Tang H. and Hool C. L., The L-Type Ca2+ Channel as a Therapeutic Target in Heart Disease, Current Medicinal Chemistry 2009; 16 (26) . https://dx.doi.org/10.2174/092986709789057671